Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast
Global Cervical Cancer Screening Market is projected to reach US$ 7 Billion by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human Papillomavirus (HPV) Virus. Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences.
Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market. Rapidly increasing female population, growing incidence of HPV infections and increasing awareness about cervical cancer screening programs is also expected to drive the cervical cancer screening market in the near future.
Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast is a market research report with published by Renub Research. The report provides a complete analysis of Global Cervical Cancer Test Market, Screened Population & Mortality.
By Test Types – VIA Screening Tests is Gaining Popularity in Developing Countries
The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests, HPV DNA Tests and VIA Tests. Pap smear and HPV DNA tests are more popular with the developed countries such as United States, Germany, United Kingdom and Others.
By Region – Asian Region is Expected to Grow Steadily during the Forecast Period
North America and Europe together dominates the Cervical Cancer Screening Market. In addition; the report also provides the complete geographical analysis of Asian and Rest of World, cervical cancer screening market.
By Country – Japan is expected to witness a slight decline in Cervical Cancer Screening Market in near Future
The report studies the market/screened population of 19 countries, which provides a complete country-wise analysis of Global Cervical Cancer Screening Market. All the 19 countries are as follows: United Kingdom, India, France, Japan, Italy, China, Sweden, Malaysia, Norway, Canada, Netherlands, Korea, United States, Germany, Switzerland, Singapore, Spain, Thailand and Indonesia
The report ‘Cervical Cancer Screening Market’ have been studied from 3 major viewpoints
Cervical Cancer Screening Market
In this section number of deaths by cervical cancer in all the 19 countries from 2011 to 2017 has been captured.
All the 19 Countries Studied in the Report are as Follows
1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. India
17. China
18. Thailand
19. Indonesia
Key Questions Answered in the Report?
Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market. Rapidly increasing female population, growing incidence of HPV infections and increasing awareness about cervical cancer screening programs is also expected to drive the cervical cancer screening market in the near future.
Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast is a market research report with published by Renub Research. The report provides a complete analysis of Global Cervical Cancer Test Market, Screened Population & Mortality.
By Test Types – VIA Screening Tests is Gaining Popularity in Developing Countries
The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests, HPV DNA Tests and VIA Tests. Pap smear and HPV DNA tests are more popular with the developed countries such as United States, Germany, United Kingdom and Others.
By Region – Asian Region is Expected to Grow Steadily during the Forecast Period
North America and Europe together dominates the Cervical Cancer Screening Market. In addition; the report also provides the complete geographical analysis of Asian and Rest of World, cervical cancer screening market.
By Country – Japan is expected to witness a slight decline in Cervical Cancer Screening Market in near Future
The report studies the market/screened population of 19 countries, which provides a complete country-wise analysis of Global Cervical Cancer Screening Market. All the 19 countries are as follows: United Kingdom, India, France, Japan, Italy, China, Sweden, Malaysia, Norway, Canada, Netherlands, Korea, United States, Germany, Switzerland, Singapore, Spain, Thailand and Indonesia
The report ‘Cervical Cancer Screening Market’ have been studied from 3 major viewpoints
Cervical Cancer Screening Market
- Pap Smear Tests Market
- HPV DNA Tests Market
- VIA Tests Market
- Pap Smear Test Population
- HPV DNA Test Population
- VIA Test Population
In this section number of deaths by cervical cancer in all the 19 countries from 2011 to 2017 has been captured.
All the 19 Countries Studied in the Report are as Follows
1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. India
17. China
18. Thailand
19. Indonesia
Key Questions Answered in the Report?
- What will be the Cervical Cancer Screening Market by 2024?
- How many women will be screened for Cervical Cancer in the recent future?
- Which country has the maximum and least market share in Cervical Cancer Screening Market?
- What will be the Pap Smear Screening Tests Market by 2024?
- What will be the HPV DNA Screening Tests Market by 2024?
- In which Region, Visual Inspection with Acetic Acid (VIA) Screening Tests is growing.
- How many deaths have occurred due to cervical cancer in each country from 2011 to 2017
1. EXECUTIVE SUMMARY
2. GLOBAL CERVICAL CANCER TEST (SCREENING) POPULATION (2011 – 2024)
2.1 Asia
2.2 Europe
2.3 North America
2.4 Rest of World
3. GLOBAL CERVICAL CANCER TEST (SCREENING) MARKET (2011 – 2024)
3.1 Pap Smear Test (Screening)
3.2 HPV DNA Test (Screening)
3.3 Visual Inspection with Acetic Acid (VIA) Test (Screening)
4. BY REGION – GLOBAL CERVICAL CANCER TEST (SCREENING) MARKET ANALYSIS (2011 – 2024)
4.1 Asia
4.2 Europe
4.3 North America
4.4 Rest of World
5. POPULATION SHARE – GLOBAL CERVICAL CANCER TEST (SCREENING) (2011 – 2024)
5.1 By Region
5.2 By Countries
6. MARKET SHARE – GLOBAL CERVICAL CANCER TEST (SCREENING) (2011 – 2024)
6.1 Region – Cervical Cancer Test (Screening)
6.2 Countries – Cervical Cancer Test (Screening)
6.3 Countries – Pap Smear Test (Screening)
6.4 Countries – HPV DNA Test (Screening)
6.5 Countries – VIA Test (Screening)
7. UNITED KINGDOM – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
7.1 Population – Cervical Cancer Test
7.1.1 Pap Smear Test Population
7.1.2 HPV DNA Test Population
7.2 United Kingdom Cervical Cancer Deaths
7.3 Market – Cervical Cancer Test (Screening)
7.3.1 Pap Smear Test Market
7.3.2 HPV DNA Test Market
8. FRANCE – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
8.1 Population – Cervical Cancer Test (Screening)
8.1.1 Pap smear Test Population
8.1.2 HPV DNA Test Population
8.2 France Cervical Cancer Mortality
8.3 Market – Cervical Cancer Test (Screening)
8.3.1 Pap Smear Test Market
8.3.2 HPV DNA Test Market
9. GERMANY – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
9.1 Population – Cervical Cancer Test (Screening)
9.1.1 Pap Smear Test Population
9.1.2 HPV DNA Test Population
9.2 Germany Cervical Cancer Mortality
9.3 Market – Cervical Cancer Test (Screening)
9.3.1 Pap Smear Test Market
9.3.2 HPV DNA Test Market & Forecast
10. ITALY – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
10.1 Population – Cervical Cancer Test (Screening)
10.1.1 Pap smear Test Population
10.1.2 HPV DNA Test Population
10.2 Italy Cervical Cancer Mortality
10.3 Market – Cervical Cancer Test (Screening)
10.3.1 Pap Smear Test Market
10.3.2 HPV DNA Test Market
11. SPAIN – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
11.1 Population – Cervical Cancer Test (Screening)
11.1.1 Pap Smear Test Population
11.1.2 HPV DNA Test Population
11.2 Spain Cervical Cancer Mortality
11.3 Market – Cervical Cancer Test (Screening)
11.3.1 Pap Smear Test Market
11.3.2 HPV DNA Test Market
12. SWEDEN – CERVICAL CANCER TEST ANALYSIS
12.1 Population – Cervical Cancer Test (Screening)
12.1.1 Pap smear Test Population
12.1.2 HPV DNA Test Population
12.2 Sweden Cervical Cancer Mortality
12.3 Market – Cervical Cancer Test (Screening)
12.3.1 Pap Smear Test Market
12.3.2 HPV DNA Test Market
13. SWITZERLAND – CERVICAL CANCER TEST ANALYSIS
13.1 Population – Cervical Cancer Test (Screening)
13.1.1 Pap smear Test Population
13.1.2 HPV DNA Test Population
13.2 Switzerland Cervical Cancer Mortality
13.3 Market – Cervical Cancer Test (Screening)
13.3.1 Pap Smear Test Market
13.3.2 HPV DNA Test Market
14. NORWAY – CERVICAL CANCER TEST ANALYSIS
14.1 Population – Cervical Cancer Test (Screening)
14.1.1 Pap smear Test Population
14.1.2 HPV DNA Test Population
14.2 Norway Cervical Cancer Mortality
14.3 Market – Cervical Cancer Test (Screening)
14.3.1 Pap Smear Test Market
14.3.2 HPV DNA Test Market
15. NETHERLANDS – CERVICAL CANCER TEST ANALYSIS
15.1 Population – Cervical Cancer Test (Screening)
15.1.1 Pap smear Test Population
15.1.2 HPV DNA Test Population
15.2 Netherlands Cervical Cancer Mortality
15.3 Market – Cervical Cancer Test (Screening)
15.3.1 Pap Smear Test Market
15.3.2 HPV DNA Test Market
16. UNITED STATES – CERVICAL CANCER TEST ANALYSIS
16.1 Population – Cervical Cancer Test (Screening)
16.1.1 Pap smear Test Population
16.1.2 HPV DNA Test Population
16.2 United States Cervical Cancer Mortality
16.3 Market – Cervical Cancer Test (Screening)
16.3.1 Pap Smear Test Market
16.3.2 HPV DNA Test Market
17. CANADA – CERVICAL CANCER TEST ANALYSIS
17.1 Population – Cervical Cancer Test (Screening)
17.1.1 Pap smear Test Population
17.1.2 HPV DNA Test Population
17.2 Canada Cervical Cancer Mortality
17.3 Market – Cervical Cancer Test (Screening)
17.3.1 Pap Smear Test Market
17.3.2 HPV DNA Test Market
18. JAPAN – CERVICAL CANCER TEST ANALYSIS
18.1 Population – Cervical Cancer Test (Screening)
18.1.1 Pap smear Test Population
18.1.2 HPV DNA Test Population
18.2 Japan Cervical Cancer Mortality
18.3 Market – Cervical Cancer Test (Screening)
18.3.1 Pap Smear Test Market
18.3.2 HPV DNA Test Market
19. SOUTH KOREA – CERVICAL CANCER TESTS ANALYSIS
19.1 Population – Cervical Cancer Test (Screening)
19.1.1 Pap smear Test Population
19.1.2 HPV DNA Test Population
19.2 Korea Cervical Cancer Mortality
19.3 Market – Cervical Cancer Test (Screening)
19.3.1 Pap Smear Test Market
19.3.2 HPV DNA Test Market
20. SINGAPORE – CERVICAL CANCER TESTS ANALYSIS
20.1 Population – Cervical Cancer Test (Screening)
20.1.1 Pap smear Test Population
20.1.2 HPV DNA Test Population
20.2 Market – Cervical Cancer Test (Screening)
20.2.1 Pap Smear Test Market
20.2.2 HPV DNA Test Market
21. MALAYSIA – CERVICAL CANCER TEST ANALYSIS
21.1 Population – Cervical Cancer Test (Screening)
21.1.1 Pap smear Test Population
21.1.2 HPV DNA Test Population
21.2 Market – Cervical Cancer Test (Screening)
21.2.1 Pap Smear Test Market
21.2.2 HPV DNA Test Market
22. INDIA – CERVICAL CANCER TEST ANALYSIS
22.1 Population – Cervical Cancer Test (Screening)
22.1.1 Pap smear Test Population
22.1.2 HPV DNA Test Population
22.1.3 Cervical Cancer VIA Test Population & Forecast
22.2 Market – Cervical Cancer Test (Screening)
22.2.1 Pap Smear Test Market
22.2.2 HPV DNA Test Market
22.2.3 VIA Test Market & Forecast
23. CHINA – CERVICAL CANCER TEST ANALYSIS
23.1 Population – Cervical Cancer Test (Screening)
23.1.1 Pap smear Test Population
23.1.2 HPV DNA Test Population
23.1.3 Cervical Cancer VIA Test Population & Forecast
23.2 Market – Cervical Cancer Test (Screening)
23.2.1 Pap Smear Test Market
23.2.2 HPV DNA Test Market
23.2.3 VIA Test Market & Forecast
24. THAILAND – CERVICAL CANCER TEST ANALYSIS
24.1 Population – Cervical Cancer Test (Screening)
24.1.1 Pap smear Test Population
24.1.2 Cervical Cancer VIA Test Population & Forecast
24.2 Market – Cervical Cancer Test (Screening)
24.2.1 Pap Smear Test Market
24.2.2 VIA Test Market & Forecast
25. INDONESIA – CERVICAL CANCER TEST ANALYSIS
25.1 Population – Cervical Cancer Test (Screening)
25.1.1 Pap smear Test Population
25.1.2 HPV DNA Test Population
25.1.3 Cervical Cancer VIA Test Population & Forecast
25.1.4 Indonesia Cervical Cancer Both (Pap smear & VIA) Test Population & Forecast
25.2 Market – Cervical Cancer Test (Screening)
25.2.1 Pap Smear Test Market
25.2.2 HPV DNA Test Market
25.2.3 VIA Test Market
25.2.4 Indonesia Cervical Cancer Both (Pap smear & VIA) Test Market & Forecast
26. REST OF WORLD – CERVICAL CANCER TEST ANALYSIS
26.1 Population – Cervical Cancer Test (Screening)
26.1.1 Pap smear Test Population
26.1.2 HPV DNA Test Population
26.2 Market – Cervical Cancer Test (Screening)
26.2.1 Pap Smear Test Market
26.2.2 HPV DNA Test Market
27. CERVICAL CANCER TEST MARKET GROWTH DRIVERS
27.1 Introduction of Low Cost VIA Test
27.1.1 Countries Offering VIA Test via National Programs
27.1.2 Countries Offering VIA Test via Pilot Programs
27.2 Worldwide High Prevalence of HPV Infected Patients
27.3 Rising Number of Incidence of Cervical Cancer in United Kingdom
27.4 Worldwide Rising Incidence of Teenage Sexual Cases
28. CHALLENGES IN CERVICAL CANCER TEST MARKET
28.1 Lack of Appropriate Healthcare Infrastructure
28.2 Introduction of HPV Vaccination Programs Worldwide
2. GLOBAL CERVICAL CANCER TEST (SCREENING) POPULATION (2011 – 2024)
2.1 Asia
2.2 Europe
2.3 North America
2.4 Rest of World
3. GLOBAL CERVICAL CANCER TEST (SCREENING) MARKET (2011 – 2024)
3.1 Pap Smear Test (Screening)
3.2 HPV DNA Test (Screening)
3.3 Visual Inspection with Acetic Acid (VIA) Test (Screening)
4. BY REGION – GLOBAL CERVICAL CANCER TEST (SCREENING) MARKET ANALYSIS (2011 – 2024)
4.1 Asia
4.2 Europe
4.3 North America
4.4 Rest of World
5. POPULATION SHARE – GLOBAL CERVICAL CANCER TEST (SCREENING) (2011 – 2024)
5.1 By Region
5.2 By Countries
6. MARKET SHARE – GLOBAL CERVICAL CANCER TEST (SCREENING) (2011 – 2024)
6.1 Region – Cervical Cancer Test (Screening)
6.2 Countries – Cervical Cancer Test (Screening)
6.3 Countries – Pap Smear Test (Screening)
6.4 Countries – HPV DNA Test (Screening)
6.5 Countries – VIA Test (Screening)
7. UNITED KINGDOM – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
7.1 Population – Cervical Cancer Test
7.1.1 Pap Smear Test Population
7.1.2 HPV DNA Test Population
7.2 United Kingdom Cervical Cancer Deaths
7.3 Market – Cervical Cancer Test (Screening)
7.3.1 Pap Smear Test Market
7.3.2 HPV DNA Test Market
8. FRANCE – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
8.1 Population – Cervical Cancer Test (Screening)
8.1.1 Pap smear Test Population
8.1.2 HPV DNA Test Population
8.2 France Cervical Cancer Mortality
8.3 Market – Cervical Cancer Test (Screening)
8.3.1 Pap Smear Test Market
8.3.2 HPV DNA Test Market
9. GERMANY – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
9.1 Population – Cervical Cancer Test (Screening)
9.1.1 Pap Smear Test Population
9.1.2 HPV DNA Test Population
9.2 Germany Cervical Cancer Mortality
9.3 Market – Cervical Cancer Test (Screening)
9.3.1 Pap Smear Test Market
9.3.2 HPV DNA Test Market & Forecast
10. ITALY – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
10.1 Population – Cervical Cancer Test (Screening)
10.1.1 Pap smear Test Population
10.1.2 HPV DNA Test Population
10.2 Italy Cervical Cancer Mortality
10.3 Market – Cervical Cancer Test (Screening)
10.3.1 Pap Smear Test Market
10.3.2 HPV DNA Test Market
11. SPAIN – CERVICAL CANCER TEST ANALYSIS (2011 – 2024)
11.1 Population – Cervical Cancer Test (Screening)
11.1.1 Pap Smear Test Population
11.1.2 HPV DNA Test Population
11.2 Spain Cervical Cancer Mortality
11.3 Market – Cervical Cancer Test (Screening)
11.3.1 Pap Smear Test Market
11.3.2 HPV DNA Test Market
12. SWEDEN – CERVICAL CANCER TEST ANALYSIS
12.1 Population – Cervical Cancer Test (Screening)
12.1.1 Pap smear Test Population
12.1.2 HPV DNA Test Population
12.2 Sweden Cervical Cancer Mortality
12.3 Market – Cervical Cancer Test (Screening)
12.3.1 Pap Smear Test Market
12.3.2 HPV DNA Test Market
13. SWITZERLAND – CERVICAL CANCER TEST ANALYSIS
13.1 Population – Cervical Cancer Test (Screening)
13.1.1 Pap smear Test Population
13.1.2 HPV DNA Test Population
13.2 Switzerland Cervical Cancer Mortality
13.3 Market – Cervical Cancer Test (Screening)
13.3.1 Pap Smear Test Market
13.3.2 HPV DNA Test Market
14. NORWAY – CERVICAL CANCER TEST ANALYSIS
14.1 Population – Cervical Cancer Test (Screening)
14.1.1 Pap smear Test Population
14.1.2 HPV DNA Test Population
14.2 Norway Cervical Cancer Mortality
14.3 Market – Cervical Cancer Test (Screening)
14.3.1 Pap Smear Test Market
14.3.2 HPV DNA Test Market
15. NETHERLANDS – CERVICAL CANCER TEST ANALYSIS
15.1 Population – Cervical Cancer Test (Screening)
15.1.1 Pap smear Test Population
15.1.2 HPV DNA Test Population
15.2 Netherlands Cervical Cancer Mortality
15.3 Market – Cervical Cancer Test (Screening)
15.3.1 Pap Smear Test Market
15.3.2 HPV DNA Test Market
16. UNITED STATES – CERVICAL CANCER TEST ANALYSIS
16.1 Population – Cervical Cancer Test (Screening)
16.1.1 Pap smear Test Population
16.1.2 HPV DNA Test Population
16.2 United States Cervical Cancer Mortality
16.3 Market – Cervical Cancer Test (Screening)
16.3.1 Pap Smear Test Market
16.3.2 HPV DNA Test Market
17. CANADA – CERVICAL CANCER TEST ANALYSIS
17.1 Population – Cervical Cancer Test (Screening)
17.1.1 Pap smear Test Population
17.1.2 HPV DNA Test Population
17.2 Canada Cervical Cancer Mortality
17.3 Market – Cervical Cancer Test (Screening)
17.3.1 Pap Smear Test Market
17.3.2 HPV DNA Test Market
18. JAPAN – CERVICAL CANCER TEST ANALYSIS
18.1 Population – Cervical Cancer Test (Screening)
18.1.1 Pap smear Test Population
18.1.2 HPV DNA Test Population
18.2 Japan Cervical Cancer Mortality
18.3 Market – Cervical Cancer Test (Screening)
18.3.1 Pap Smear Test Market
18.3.2 HPV DNA Test Market
19. SOUTH KOREA – CERVICAL CANCER TESTS ANALYSIS
19.1 Population – Cervical Cancer Test (Screening)
19.1.1 Pap smear Test Population
19.1.2 HPV DNA Test Population
19.2 Korea Cervical Cancer Mortality
19.3 Market – Cervical Cancer Test (Screening)
19.3.1 Pap Smear Test Market
19.3.2 HPV DNA Test Market
20. SINGAPORE – CERVICAL CANCER TESTS ANALYSIS
20.1 Population – Cervical Cancer Test (Screening)
20.1.1 Pap smear Test Population
20.1.2 HPV DNA Test Population
20.2 Market – Cervical Cancer Test (Screening)
20.2.1 Pap Smear Test Market
20.2.2 HPV DNA Test Market
21. MALAYSIA – CERVICAL CANCER TEST ANALYSIS
21.1 Population – Cervical Cancer Test (Screening)
21.1.1 Pap smear Test Population
21.1.2 HPV DNA Test Population
21.2 Market – Cervical Cancer Test (Screening)
21.2.1 Pap Smear Test Market
21.2.2 HPV DNA Test Market
22. INDIA – CERVICAL CANCER TEST ANALYSIS
22.1 Population – Cervical Cancer Test (Screening)
22.1.1 Pap smear Test Population
22.1.2 HPV DNA Test Population
22.1.3 Cervical Cancer VIA Test Population & Forecast
22.2 Market – Cervical Cancer Test (Screening)
22.2.1 Pap Smear Test Market
22.2.2 HPV DNA Test Market
22.2.3 VIA Test Market & Forecast
23. CHINA – CERVICAL CANCER TEST ANALYSIS
23.1 Population – Cervical Cancer Test (Screening)
23.1.1 Pap smear Test Population
23.1.2 HPV DNA Test Population
23.1.3 Cervical Cancer VIA Test Population & Forecast
23.2 Market – Cervical Cancer Test (Screening)
23.2.1 Pap Smear Test Market
23.2.2 HPV DNA Test Market
23.2.3 VIA Test Market & Forecast
24. THAILAND – CERVICAL CANCER TEST ANALYSIS
24.1 Population – Cervical Cancer Test (Screening)
24.1.1 Pap smear Test Population
24.1.2 Cervical Cancer VIA Test Population & Forecast
24.2 Market – Cervical Cancer Test (Screening)
24.2.1 Pap Smear Test Market
24.2.2 VIA Test Market & Forecast
25. INDONESIA – CERVICAL CANCER TEST ANALYSIS
25.1 Population – Cervical Cancer Test (Screening)
25.1.1 Pap smear Test Population
25.1.2 HPV DNA Test Population
25.1.3 Cervical Cancer VIA Test Population & Forecast
25.1.4 Indonesia Cervical Cancer Both (Pap smear & VIA) Test Population & Forecast
25.2 Market – Cervical Cancer Test (Screening)
25.2.1 Pap Smear Test Market
25.2.2 HPV DNA Test Market
25.2.3 VIA Test Market
25.2.4 Indonesia Cervical Cancer Both (Pap smear & VIA) Test Market & Forecast
26. REST OF WORLD – CERVICAL CANCER TEST ANALYSIS
26.1 Population – Cervical Cancer Test (Screening)
26.1.1 Pap smear Test Population
26.1.2 HPV DNA Test Population
26.2 Market – Cervical Cancer Test (Screening)
26.2.1 Pap Smear Test Market
26.2.2 HPV DNA Test Market
27. CERVICAL CANCER TEST MARKET GROWTH DRIVERS
27.1 Introduction of Low Cost VIA Test
27.1.1 Countries Offering VIA Test via National Programs
27.1.2 Countries Offering VIA Test via Pilot Programs
27.2 Worldwide High Prevalence of HPV Infected Patients
27.3 Rising Number of Incidence of Cervical Cancer in United Kingdom
27.4 Worldwide Rising Incidence of Teenage Sexual Cases
28. CHALLENGES IN CERVICAL CANCER TEST MARKET
28.1 Lack of Appropriate Healthcare Infrastructure
28.2 Introduction of HPV Vaccination Programs Worldwide
LIST OF FIGURES:
Figure 2-1: Global – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-2: Global – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2-3: Asia – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-4: Asia – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2-5: Europe – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-6: Europe – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2-7: North America – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-8: North America – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 3-1: Global – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 3-2: Global – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 3-3: Global – Cervical Cancer Pap Smear Test Market (Million US$), 2011 – 2017
Figure 3-4: Global – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2018 – 2024
Figure 3-5: Global – Cervical Cancer HPV DNA Test Market (Million US$), 2011 – 2017
Figure 3-6: Global – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2018 – 2024
Figure 3-7: Global – Cervical Cancer VIA Test Market (Million US$), 2011 – 2017
Figure 3-8: Global – Forecast for Cervical Cancer VIA Test Market (Million US$), 2018 – 2024
Figure 4-1: Asia – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4-2: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 4-3: Europe – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4-4: Europe – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 4-5: North America – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4-6: North America – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 5-1: Global - Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2011 – 2017
Figure 5-2: Global – Forecast for Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2018 – 2024
Figure 6-1: Global – Cervical Cancer Market Share (Percent) By Region, 2011 – 2017
Figure 6-2: Global – Forecast for Cervical Cancer Market Share (Percent) By Region, 2018 – 2024
Figure 7-1: United Kingdom – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 7-2: United Kingdom – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 7-3: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 7-4: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 7-5: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 7-6: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 7-7: United Kingdom – Cervical Cancer Deaths (Number), 2011 – 2017
Figure 7-8: United Kingdom – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 7-9: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 7-10: United Kingdom – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 7-11: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 7-12: United Kingdom – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 7-13: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 8-1: France – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 8-2: France – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 8-3: France – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 8-4: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 8-5: France – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 8-6: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 8-7: France – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 8-8: France – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 8-9: France – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 8-10: France – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 8-11: France – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 8-12: France – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 8-13: France – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 9-1: Germany – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 9-2: Germany – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 9-3: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 9-4: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 9-5: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 9-6: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 9-7: Germany – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 9-8: Germany – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 9-9: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 9-10: Germany – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 9-11: Germany – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 9-12: Germany – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 9-13: Germany – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 10-1: Italy – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 10-2: Italy – Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 10-3: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 10-4: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 – 2024
Figure 10-5: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 10-6: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 10-7: Italy – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 10-8: Italy – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 10-9: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 10-10: Italy – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 10-11: Italy – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 10-12: Italy – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 10-13: Italy – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 11-1: Spain – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 11-2: Spain – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 11-3: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 11-4: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 11-5: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 11-6: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 –2024
Figure 11-7: Spain – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 11-8: Spain – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 11-9: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 11-10: Spain – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 11-11: Spain – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 11-12: Spain – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 11-13: Spain – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 12-1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 12-2: Sweden – Forecast for Cervical Cancer Pap smear Test Population (Thousand), 2018 – 2024
Figure 12-3: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 12-4: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 12-5: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 12-6: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 12-7: Sweden – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 12-8: Sweden – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 12-9: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 12-10: Sweden – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 12-11: Sweden – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 12-12: Sweden – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 12-13: Sweden – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 13-1: Switzerland – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 13-2: Switzerland – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 13-3: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 13-4: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 13-5: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 13-6: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 13-7: Switzerland – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 13-8: Switzerland – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 13-9: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 13-10: Switzerland – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 13-11: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 13-12: Switzerland – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 13-13: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 14-1: Norway – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 14-2: Norway – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 14-3: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 14-4: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 14-5: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 14-6: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 14-7: Norway – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 14-8: Norway – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 14-9: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 14-10: Norway – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 14-11: Norway – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 14-12: Norway – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 14-13: Norway – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 15-1: Netherlands – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 15-2: Netherlands – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 15-3: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 15-4: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 15-5: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 15-6: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 15-7: Netherlands – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 15-8: Netherlands – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 15-9: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 15-10: Netherlands – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 15-11: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 15-12: Netherlands – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 15-13: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 16-1: United States – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 16-2: United States – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 16-3: United States – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 16-4: United States – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 16-5: United States – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 16-6: United States – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 16-7: United States – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 16-8: United States – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 16-9: United States – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 16-10: United States – Pap smear Test Market (Million US$), 2011 – 2017
Figure 16-11: United States – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 16-12: United States – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 16-13: United States – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 17-1: Canada – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 17-2: Canada – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 17-3: Canada – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 17-4: Canada – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 17-5: Canada – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 17-6: Canada – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 17-7: Canada – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 17-8: Canada – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 17-9: Canada – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2022
Figure 17-10: Canada – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 17-11: Canada – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 17-12: Canada – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 17-13: Canada – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 18-1: Japan – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 18-2: Japan – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 18-3: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 18-4: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 18-5: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 18-6: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 18-7: Japan – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 18-8: Japan – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 18-9: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 18-10: Japan – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 18-11: Japan – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 18-12: Japan – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 18-13: Japan – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 19-1: Korea – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 19-2: Korea – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 19-3: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 19-4: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 19-5: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 19-6: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 19-7: Korea – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 19-8: Korea – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 19-9: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 19-10: Korea – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 19-11: Korea – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 19-12: Korea – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 19-13: Korea – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 20-1: Singapore – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 20-2: Singapore – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 20-3: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 20-4: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 20-5: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 20-6: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 20-7: Singapore – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 20-8: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 20-9: Singapore – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 20-10: Singapore – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 20-11: Singapore – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 20-12: Singapore – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 21-1: Malaysia – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 21-2: Malaysia – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 21-3: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 21-4: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 21-5: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 21-6: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 21-7: Malaysia – Cervical Cancer Test Market (Million US$), 2011– 2017
Figure 21-8: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 21-9: Malaysia – Pap smear Test Market (Million US$), 2011 – 2017
Figure 21-10: Malaysia – Forecast for Pap smear Test Market (Million US$), 2018 – 2024
Figure 21-11: Malaysia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 21-12: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2018– 2024
Figure 22-1: India – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 22-2: India – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 22-3: India – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 22-4: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 22-5: India – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 22-6: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 22-7: India – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 22-8: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 22-9: India – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 22-10: India – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 22-11: India – Pap smear Test Market (Million US$), 2011 – 2017
Figure 22-12: India – Forecast for Pap smear Test Market (Million US$), 2018 – 2024
Figure 22-13: India – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 22-14: India – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 22-15: India – VIA Test Market (Million US$), 2011 – 2017
Figure 22-16: India – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 23-1: China – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 23-2: China – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 23-3: China – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 23-4: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 23-5: China – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 23-6: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 23-7: China – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 23-8: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 23-9: China – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 23-10: China – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 23-11: China – Pap smear Test Market (Million US$), 2011 – 2017
Figure 23-12: China – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 23-13: China – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 23-14: China – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 23-15: China – VIA Test Market (Million US$), 2011 – 2017
Figure 23-16: China – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 24-1: Thailand – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 24-2: Thailand – Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 24-3: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 24-4: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 24-5: Thailand – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 24-6: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 24-7: Thailand – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 24-8: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 24-9: Thailand – Pap smear Test Market (Million US$), 2011 – 2017
Figure 24-10: Thailand – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 24-11: Thailand – VIA Test Market (Million US$), 2011 – 2017
Figure 24-12: Thailand – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 25-1: Indonesia – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 25-2: Indonesia – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 25-3: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 25-4: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 25-5: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 25-6: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 25-7: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 25-8: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 25-9: Indonesia – Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2011 – 2017
Figure 25-10: Indonesia – Forecast for Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2018 – 2024
Figure 25-11: Indonesia – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 25-12: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 25-13: Indonesia – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 25-14: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 25-15: Indonesia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 25-16: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 25-17: Indonesia – VIA Test Market (Million US$), 2011 – 2017
Figure 25-18: Indonesia – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 25-19: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2011 – 2017
Figure 25-20: Indonesia – Forecast for Both (Pap smear & VIA) Test Market (Million US$), 2018 – 2024
Figure 2-1: Global – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-2: Global – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2-3: Asia – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-4: Asia – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2-5: Europe – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-6: Europe – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2-7: North America – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2-8: North America – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 3-1: Global – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 3-2: Global – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 3-3: Global – Cervical Cancer Pap Smear Test Market (Million US$), 2011 – 2017
Figure 3-4: Global – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2018 – 2024
Figure 3-5: Global – Cervical Cancer HPV DNA Test Market (Million US$), 2011 – 2017
Figure 3-6: Global – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2018 – 2024
Figure 3-7: Global – Cervical Cancer VIA Test Market (Million US$), 2011 – 2017
Figure 3-8: Global – Forecast for Cervical Cancer VIA Test Market (Million US$), 2018 – 2024
Figure 4-1: Asia – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4-2: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 4-3: Europe – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4-4: Europe – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 4-5: North America – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4-6: North America – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 5-1: Global - Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2011 – 2017
Figure 5-2: Global – Forecast for Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2018 – 2024
Figure 6-1: Global – Cervical Cancer Market Share (Percent) By Region, 2011 – 2017
Figure 6-2: Global – Forecast for Cervical Cancer Market Share (Percent) By Region, 2018 – 2024
Figure 7-1: United Kingdom – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 7-2: United Kingdom – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 7-3: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 7-4: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 7-5: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 7-6: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 7-7: United Kingdom – Cervical Cancer Deaths (Number), 2011 – 2017
Figure 7-8: United Kingdom – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 7-9: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 7-10: United Kingdom – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 7-11: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 7-12: United Kingdom – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 7-13: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 8-1: France – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 8-2: France – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 8-3: France – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 8-4: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 8-5: France – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 8-6: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 8-7: France – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 8-8: France – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 8-9: France – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 8-10: France – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 8-11: France – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 8-12: France – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 8-13: France – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 9-1: Germany – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 9-2: Germany – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 9-3: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 9-4: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 9-5: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 9-6: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 9-7: Germany – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 9-8: Germany – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 9-9: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 9-10: Germany – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 9-11: Germany – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 9-12: Germany – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 9-13: Germany – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 10-1: Italy – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 10-2: Italy – Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 10-3: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 10-4: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 – 2024
Figure 10-5: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 10-6: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 10-7: Italy – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 10-8: Italy – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 10-9: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 10-10: Italy – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 10-11: Italy – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 10-12: Italy – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 10-13: Italy – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 11-1: Spain – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 11-2: Spain – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 11-3: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 11-4: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 11-5: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 11-6: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 –2024
Figure 11-7: Spain – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 11-8: Spain – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 11-9: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 11-10: Spain – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 11-11: Spain – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 11-12: Spain – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 11-13: Spain – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 12-1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 12-2: Sweden – Forecast for Cervical Cancer Pap smear Test Population (Thousand), 2018 – 2024
Figure 12-3: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 12-4: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 12-5: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 12-6: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 12-7: Sweden – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 12-8: Sweden – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 12-9: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 12-10: Sweden – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 12-11: Sweden – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 12-12: Sweden – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 12-13: Sweden – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 13-1: Switzerland – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 13-2: Switzerland – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 13-3: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 13-4: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 13-5: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 13-6: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 13-7: Switzerland – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 13-8: Switzerland – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 13-9: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 13-10: Switzerland – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 13-11: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 13-12: Switzerland – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 13-13: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 14-1: Norway – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 14-2: Norway – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 14-3: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 14-4: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 14-5: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 14-6: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 14-7: Norway – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 14-8: Norway – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 14-9: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 14-10: Norway – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 14-11: Norway – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 14-12: Norway – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 14-13: Norway – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 15-1: Netherlands – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 15-2: Netherlands – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 15-3: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 15-4: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 15-5: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 15-6: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 15-7: Netherlands – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 15-8: Netherlands – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 15-9: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 15-10: Netherlands – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 15-11: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 15-12: Netherlands – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 15-13: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 16-1: United States – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 16-2: United States – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 16-3: United States – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 16-4: United States – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 16-5: United States – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 16-6: United States – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 16-7: United States – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 16-8: United States – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 16-9: United States – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 16-10: United States – Pap smear Test Market (Million US$), 2011 – 2017
Figure 16-11: United States – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 16-12: United States – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 16-13: United States – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 17-1: Canada – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 17-2: Canada – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 17-3: Canada – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 17-4: Canada – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 17-5: Canada – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 17-6: Canada – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 17-7: Canada – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 17-8: Canada – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 17-9: Canada – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2022
Figure 17-10: Canada – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 17-11: Canada – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 17-12: Canada – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 17-13: Canada – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 18-1: Japan – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 18-2: Japan – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 18-3: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 18-4: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 18-5: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 18-6: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 18-7: Japan – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 18-8: Japan – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 18-9: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 18-10: Japan – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 18-11: Japan – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 18-12: Japan – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 18-13: Japan – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 19-1: Korea – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 19-2: Korea – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 19-3: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 19-4: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 19-5: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 19-6: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 19-7: Korea – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 19-8: Korea – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 19-9: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 19-10: Korea – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 19-11: Korea – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 19-12: Korea – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 19-13: Korea – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 20-1: Singapore – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 20-2: Singapore – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 20-3: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 20-4: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 20-5: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 20-6: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 20-7: Singapore – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 20-8: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 20-9: Singapore – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 20-10: Singapore – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 20-11: Singapore – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 20-12: Singapore – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 21-1: Malaysia – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 21-2: Malaysia – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 21-3: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 21-4: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 21-5: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 21-6: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 21-7: Malaysia – Cervical Cancer Test Market (Million US$), 2011– 2017
Figure 21-8: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 21-9: Malaysia – Pap smear Test Market (Million US$), 2011 – 2017
Figure 21-10: Malaysia – Forecast for Pap smear Test Market (Million US$), 2018 – 2024
Figure 21-11: Malaysia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 21-12: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2018– 2024
Figure 22-1: India – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 22-2: India – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 22-3: India – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 22-4: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 22-5: India – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 22-6: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 22-7: India – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 22-8: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 22-9: India – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 22-10: India – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 22-11: India – Pap smear Test Market (Million US$), 2011 – 2017
Figure 22-12: India – Forecast for Pap smear Test Market (Million US$), 2018 – 2024
Figure 22-13: India – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 22-14: India – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 22-15: India – VIA Test Market (Million US$), 2011 – 2017
Figure 22-16: India – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 23-1: China – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 23-2: China – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 23-3: China – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 23-4: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 23-5: China – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 23-6: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 23-7: China – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 23-8: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 23-9: China – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 23-10: China – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 23-11: China – Pap smear Test Market (Million US$), 2011 – 2017
Figure 23-12: China – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 23-13: China – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 23-14: China – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 23-15: China – VIA Test Market (Million US$), 2011 – 2017
Figure 23-16: China – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 24-1: Thailand – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 24-2: Thailand – Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 24-3: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 24-4: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 24-5: Thailand – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 24-6: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 24-7: Thailand – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 24-8: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 24-9: Thailand – Pap smear Test Market (Million US$), 2011 – 2017
Figure 24-10: Thailand – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 24-11: Thailand – VIA Test Market (Million US$), 2011 – 2017
Figure 24-12: Thailand – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 25-1: Indonesia – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 25-2: Indonesia – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 25-3: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 25-4: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 25-5: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 25-6: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 25-7: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 25-8: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 25-9: Indonesia – Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2011 – 2017
Figure 25-10: Indonesia – Forecast for Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2018 – 2024
Figure 25-11: Indonesia – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 25-12: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 25-13: Indonesia – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 25-14: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 25-15: Indonesia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 25-16: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 25-17: Indonesia – VIA Test Market (Million US$), 2011 – 2017
Figure 25-18: Indonesia – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 25-19: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2011 – 2017
Figure 25-20: Indonesia – Forecast for Both (Pap smear & VIA) Test Market (Million US$), 2018 – 2024
